AI Article Synopsis
- - A previously healthy young man experienced severe coughing up of blood (hemoptysis) two months after a mild case of COVID-19, with no other health issues identified.
- - He was effectively treated through a procedure called bronchial artery embolization, which blocks blood flow to the affected area.
- - The case suggests that even mild COVID-19 infections can lead to delayed and unusual complications, potentially due to autoimmune responses, broadening our understanding of the mid-term effects of the disease.
Article Abstract
An otherwise healthy young man presented with massive hemoptysis 2 month following a mild coronavirus disease 2019 (COVID-19) and with no other identifiable cause of illness. The patient was successfully treated with bronchial artery embolization. We are strongly convinced that hemoptysis in this case was COVID-related. This unusual case of delayed COVID-related hemoptysis reveals new aspects in the understanding of mid-term and presumable auto-immune triggered effects in patients with initially only mild symptoms of the disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759770 | PMC |
| http://dx.doi.org/10.1016/j.radcr.2021.12.048 | DOI Listing |
Publication Analysis
Top Keywords
massive hemoptysis
8
treated bronchial
8
bronchial artery
8
artery embolization
8
hemoptysis months
4
months mild
4
mild sars-cov-2
4
sars-cov-2 disease
4
disease covid-19
4
covid-19 treated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!